Acasti Pharma Inc. (ACST)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.35+0.04 (+3.05%)
At close: 4:00 PM EDT
People also watch:
NEPTACURABIOBGMDADMP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open1.36
Prev Close1.31
Bid1.31 x 1400
Ask12.50 x 500
Day's Range1.31 - 1.36
52wk Range1.20 - 3.80
1y Target EstN/A
Market Cap14.46M
P/E Ratio (ttm)-2.17
Beta0.90
Volume1,928
Avg Vol (3m)25,892
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q1, 2017 By the Numbers : July 22, 2016
    Capital Cubelast month

    Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q1, 2017 By the Numbers : July 22, 2016

    Click here to see latest analysisAcasti Pharma, Inc. reports financial results for the quarter ended May 31, 2016.HighlightsSummary numbers: Revenues of USD 0.00 million, Net Earnings of USD -2.42 million.Gross margins narrowed from -11,357.12% to -20,974.65% compared to the same period last year, operating (EBITDA) margins now -82,173.61% from -39,469.07%.Change in operating cash flow of […] (Read more...) The post Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q1, 2017 By the Numbers : July 22, 2016 appeared first on CapitalCube.

  • Marketwiredlast month

    Acasti Announces the Election of its Directors, Change of Fiscal Year End and Other Related Matters Passed at its AGM

    Acasti Pharma Inc. of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of hypertriglyceridemia, announced that the nominees listed in its management proxy circular dated June ...

  • Associated Presslast month

    Acasti reports 1Q loss

    The Laval, Quebec-based company said it had a loss of 23 cents per share. The biopharmaceutical company posted revenue of $2,000 in the period. In the final minutes of trading on Monday, the company's ...